Blog - Page 8 of 17 - SOFIE

Fibroblast Activation Protein-Targeted PET/CT with 18F-Fibroblast Activation Protein Inhibitor-74 for Evaluation of Gastrointestinal Cancer: Comparison with 18F-FDG PET/CT
Gallery
Fibroblast Activation Protein-Targeted PET/CT with 18F-Fibroblast Activation Protein Inhibitor-74 for Evaluation of Gastrointestinal Cancer: Comparison with 18F-FDG PET/CT

Fibroblast Activation Protein-Targeted PET/CT with 18F-Fibroblast Activation Protein Inhibitor-74 for Evaluation of Gastrointestinal Cancer: Comparison with 18F-FDG PET/CT

Weizhi Xu, Jiayu Cai, Tianxing Peng, Tinghua Meng, Yizhen Pang, Long Sun, Hua Wu, Jingjing […]

sofie_c557hm2025-10-15T16:39:29+00:0020, Oct 2023|Publications|

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers
Gallery
SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

A global licensing agreement has been signed for the development and […]

Patrick Phelps2025-10-15T16:42:14+00:0011, Oct 2023|News|

Head-to-Head Intra-Individual Comparison of Biodistribution and Tumor Uptake of [18F]FAPI-74 with [18F]FDG in Patients with PDAC: A Prospective Exploratory Study
Gallery
Head-to-Head Intra-Individual Comparison of Biodistribution and Tumor Uptake of [18F]FAPI-74 with [18F]FDG in Patients with PDAC: A Prospective Exploratory Study

Head-to-Head Intra-Individual Comparison of Biodistribution and Tumor Uptake of [18F]FAPI-74 with [18F]FDG in Patients with PDAC: A Prospective Exploratory Study

Emil Novruzov¹, Frederik L Giesel^1,2, Yuriko Mori¹, Peter L Choyke³, Mardjan Dabir¹, Eduards Mamlins¹, Dominik […]

sofie_c557hm2025-10-15T16:39:29+00:0029, Aug 2023|Publications|

Comparison of Baseline 68Ga-FAPI and 18F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib
Gallery
Comparison of Baseline 68Ga-FAPI and 18F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib

Comparison of Baseline 68Ga-FAPI and 18F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib

Meiqi Wu¹, Yanyu Wang², Qiao Yang¹, Xuezhu Wang¹, Xu Yang², Haiqun Xing¹, Xinting Sang², Xiang […]

sofie_c557hm2025-10-15T16:40:44+00:0029, Aug 2023|Publications|

Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis
Gallery
Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis

Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis

Alessio Rizzo¹, Manuela Racca¹, Federico Garrou², Elisabetta Fenocchio³, Luca Pellegrino⁴, Domenico Albano⁵, Francesco Dondi⁵, Francesco […]

sofie_c557hm2025-10-15T16:39:33+00:0029, Aug 2023|Publications|

Fibroblast Activation Protein (FAP) – a target for Imaging and Therapy
Gallery
Fibroblast Activation Protein (FAP) – a target for Imaging and Therapy

Fibroblast Activation Protein (FAP) – a target for Imaging and Therapy

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
Targeted Radiopharmaceuticals Summit US (TRP) – Boston, […]

sofie_c557hm2025-11-03T16:06:22+00:0025, Jul 2023|Presentations|

FAP symposium another success at 2023 SNMMI meeting
Gallery
FAP symposium another success at 2023 SNMMI meeting

FAP symposium another success at 2023 SNMMI meeting

June 25, 2023 – For the second year in a row, the spotlight shone on […]

Patrick Phelps2025-10-15T16:42:11+00:007, Jul 2023|News|

SOFIE FAPI diagnostic-clinical development updates
Gallery
SOFIE FAPI diagnostic-clinical development updates

SOFIE FAPI diagnostic-clinical development updates

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2023 Annual SNMMI Meeting – Chicago, Illinois
June […]

sofie_c557hm2025-11-03T16:08:36+00:0025, Jun 2023|Presentations|

FAP Radioligands for Imaging and Therapy
Gallery
FAP Radioligands for Imaging and Therapy

FAP Radioligands for Imaging and Therapy

Watch Webinar

sofie_c557hm2026-06-03T01:06:38+00:0024, Jun 2023|Presentations|

Previous 789 Next